David Taber to Pancreas Transplantation
This is a "connection" page, showing publications David Taber has written about Pancreas Transplantation.
Connection Strength
1.126
-
Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients. Ann Pharmacother. 2007 Jun; 41(6):944-50.
Score: 0.266
-
The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation. Am J Surg. 2022 04; 223(4):812-816.
Score: 0.177
-
Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality. Clin Transplant. 2019 10; 33(10):e13695.
Score: 0.157
-
Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes. Exp Clin Transplant. 2019 12; 17(6):796-802.
Score: 0.148
-
Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation. 2014 Mar 27; 97(6):681-5.
Score: 0.107
-
Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
Score: 0.055
-
Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplantation. 2004 Aug 27; 78(4):619-22.
Score: 0.055
-
Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc. 2004 May; 36(4):1048-9.
Score: 0.054
-
Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplant Proc. 2004 May; 36(4):1058-60.
Score: 0.054
-
Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101.
Score: 0.052